telitacicept: Clinical Trials

4 trials of telitacicept, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 not yet recruiting. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Active not recruiting 1, Not yet recruiting 1
Phase 21Active not recruiting 1

Follow telitacicept: new trials by email Literature Review of telitacicept trials Research Report on telitacicept

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IBI3034 Study in Healthy Adults and Patients With Primary IgA Nephropathy
IBI3034, Placebo, Telitacicept - IgA Nephropathy (IgAN)
Phase 1Not yet recruitingInnovent Biologics (Suzhou) Co. Ltd.1002026-10-152026-10-21
The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)
Telitacicept 160mg, Prednisone (and methylprednisolone), Cyclophosphamide - Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN)
Phase 1 / Phase 2Active not recruitingRenmin Hospital of Wuhan University152024-10-102024-10-24
A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus
Telitacicept - Systemic Lupus Erythematosus
Phase 1CompletedRemeGen Co., Ltd.162023-05-252026-03-09
Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus
Telitacicept, standard therapy - Systemic Lupus Erythematosus
Phase 1CompletedRemeGen Co., Ltd.922022-05-112023-12-06

Conditions studied

Lupus Erythematosus, Systemic (2)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Autoimmune Diseases (1)  ·  Connective Tissue Diseases (1)  ·  Glomerulonephritis, IGA (1)

Sponsors

RemeGen Co., Ltd. (2)  ·  Innovent Biologics (Suzhou) Co. Ltd. (1)  ·  Renmin Hospital of Wuhan University (1)

Countries

China (4)

Top investigators

Hongmei Song, M.D. (1)